USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$828.35M
Market Cap
-
P/E Ratio
-1.06
EPS
$5.33
52 Week High
$1.26
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$15M |
Total Revenue | $0 |
Cost Of Revenue | $15M |
Costof Goods And Services Sold | $15M |
Operating Income | -$273M |
Selling General And Administrative | $64M |
Research And Development | $218M |
Operating Expenses | $282M |
Investment Income Net | - |
Net Interest Income | $10M |
Interest Income | $10M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $15M |
Income Before Tax | -$267M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$267M |
Comprehensive Income Net Of Tax | - |
Ebit | -$267M |
Ebitda | -$251M |
Net Income | -$267M |
Field | Value (USD) |
---|---|
Total Assets | $501M |
Total Current Assets | $161M |
Cash And Cash Equivalents At Carrying Value | $128M |
Cash And Short Term Investments | $128M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $340M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $59M |
Intangible Assets Excluding Goodwill | $59M |
Goodwill | $141M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $25M |
Other Current Assets | $8.3M |
Other Non Current Assets | - |
Total Liabilities | $251M |
Total Current Liabilities | $45M |
Current Accounts Payable | $5.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $13M |
Total Non Current Liabilities | $205M |
Capital Lease Obligations | $94M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $94M |
Other Current Liabilities | $28M |
Other Non Current Liabilities | $123M |
Total Shareholder Equity | $251M |
Treasury Stock | - |
Retained Earnings | -$1.6B |
Common Stock | $22K |
Common Stock Shares Outstanding | $231M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$223M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $17M |
Capital Expenditures | $33M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $17M |
Cashflow From Financing | $200M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$267M |
Field | Value (USD) |
---|---|
Gross Profit | -$15M |
Total Revenue | $0 |
Cost Of Revenue | $15M |
Costof Goods And Services Sold | $15M |
Operating Income | -$273M |
Selling General And Administrative | $64M |
Research And Development | $218M |
Operating Expenses | $282M |
Investment Income Net | - |
Net Interest Income | $10M |
Interest Income | $10M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $15M |
Income Before Tax | -$267M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$267M |
Comprehensive Income Net Of Tax | - |
Ebit | -$267M |
Ebitda | -$251M |
Net Income | -$267M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.